M V N L Chaitanya – författare

This book reviews the evolving field of epigenetics and its implications for drug discovery and precision medicine. It also focuses on the intricate mechanisms governing gene regulation and the impact of epigenetics on health and disease. The book encompasses the complexities of epigenetic mechanisms and their role in diseases such as cancer, autoimmune disorders, inflammatory conditions, and neurodegenerative diseases. Additionally, it examines the role of miRNA as an epigenetic drug in treating cancer and in-silico approaches to epigenetic drug discovery. The book uncovers the potential of epigenetic drug discovery, including insights into traditional medicine, marine sources, and OMICS technologies. Moreover, it explores the interplay between gut microbiota, probiotics, and prebiotics in epigenetic therapeutic approaches. With a focus on personalized medicine and recent advancements in drug delivery systems, this book is intended for researchers, clinicians, and pharmaceutical professionals seeking to explore epigenetic drug discovery and development.Key featuresDiscusses the implications of epigenetic mechanisms in different diseases and epigenetic based drug discoveryReviews development of targeted therapies based on epigenetic mechanisms for cancer, autoimmune diseases, neurodegenerative conditions, and inflammatory diseasesEmphasizes the importance of precision medicine and personalized therapies based on epigenetic profilingExplores application of artificial intelligence in designing novel delivery systems for epigenetic drugsPresents role of advance in-silico and drug discovery tools in the development of epigenetic drugs

This book reviews the evolving field of epigenetics and its implications for drug discovery and precision medicine. It also focuses on the intricate mechanisms governing gene regulation and the impact of epigenetics on health and disease. The book encompasses the complexities of epigenetic mechanisms and their role in diseases such as cancer, autoimmune disorders, inflammatory conditions, and neurodegenerative diseases. Additionally, it examines the role of miRNA as an epigenetic drug in treating cancer and in-silico approaches to epigenetic drug discovery. The book uncovers the potential of epigenetic drug discovery, including insights into traditional medicine, marine sources, and OMICS technologies. Moreover, it explores the interplay between gut microbiota, probiotics, and prebiotics in epigenetic therapeutic approaches. With a focus on personalized medicine and recent advancements in drug delivery systems, this book is intended for researchers, clinicians, and pharmaceutical professionals seeking to explore epigenetic drug discovery and development.Key features Discusses the implications of epigenetic mechanisms in different diseases and epigenetic based drug discovery Reviews development of targeted therapies based on epigenetic mechanisms for cancer, autoimmune diseases, neurodegenerative conditions, and inflammatory diseases Emphasizes the importance of precision medicine and personalized therapies based on epigenetic profiling Explores application of artificial intelligence in designing novel delivery systems for epigenetic drugs Presents role of advance in-silico and drug discovery tools in the development of epigenetic drugs